This finding underscores the importance of incorporating remission as a core element of modern T2D prevention strategies, regardless of baseline
Among these, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have gained considerable attention for their dual benefits in glycemic control and weight reduction
Ozempic: Available as a generic: no Active ingredient: semaglutide Trulicity: Available as a biosimilar: no Active ingredient: dulaglutide The Food and Drug Administration (FDA) approves prescription drugs such as Ozempic and Trulicity to treat or prevent certain conditions
Multi-omics detection methods combine technologies such as genomics, transcriptomics, and proteomics, offering new perspectives for investigating the mechanisms of HGSOC drug resistance (109, 110)
Patient assistance programs Many GLP-1 medications offer patient assistance programs to lower the cost of these medications for patients
Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients